Indium (In111) Chloride Curium Netherlands

Indium-111 chloride, the active ingredient in Indium (In111) Chloride Curium Netherlands, is a radiopharmaceutical presented as a solution for injection for intravenous use. It is employed to image infection, inflammation, bone marrow activity, and tumor tissue in adult patients.

GNH USA supplies Indium (In111) Chloride Curium Netherlands as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, oncology centres, and clinics worldwide.

Indium-111 chloride is employed in nuclear medicine imaging to localize infection, inflammation, bone marrow activity, and tumor tissue.

- Localization of infection and inflammation: enables scintigraphic detection of infectious foci and inflammatory lesions. - Bone marrow imaging: visualizes marrow distribution and activity for diagnostic assessment. - Tumor and lymphoma imaging: assists in identifying malignant lesions and evaluating disease extent. - Leukocyte labeling for infection detection: tags white blood cells to pinpoint sites of infection.

Adverse reactions may occur following administration of Indium-111 chloride.

Common Side Effects: - Injection site pain: mild discomfort at the puncture site. - Transient flushing: brief feeling of warmth. - Mild nausea: occasional stomach upset. - Headache: short‑lasting headache.

Serious or Rare Side Effects: - Allergic reaction (anaphylaxis): severe hypersensitivity requiring immediate care. - Radiation‑induced skin injury: localized skin changes at high exposure. - Bone marrow suppression (rare): transient decrease in blood cell counts. - Severe hypotension: sudden drop in blood pressure post‑injection.

Prior to use, clinicians should consider several safety measures. - Pregnancy: use only if the diagnostic benefit outweighs potential fetal radiation risk. - Breastfeeding: discontinue nursing or assess risk versus benefit. - Renal impairment: evaluate clearance and consider dose adjustment. - Concurrent radiopharmaceuticals: avoid overlapping imaging studies to prevent excess radiation. - Radiation safety: follow ALARA principles to protect staff and patients. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Indium-111 chloride may interact with other agents used in diagnostic or therapeutic settings.

Major Interactions (Avoid): - Concurrent gamma‑emitting radiopharmaceuticals: overlapping radiation fields can compromise image quality and increase dose. - Bone‑marrow suppressive chemotherapy: may exacerbate hematologic toxicity.

Moderate Interactions (Monitor Closely): - Iodinated contrast agents used in CT: may affect image interpretation. - Antihistamines: could mask mild allergic responses. - Beta‑blockers: may influence hemodynamic response to injection.